Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 45

    1.

    Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis.

    Deuffic-Burban S, Mathurin P, Pol S, Larsen C, Roudot-Thoraval F, Desenclos JC, Dhumeaux D, Yazdanpanah Y.

    Gut. 2012 Feb;61(2):290-6. Epub 2011 Sep 19.

    PMID:
    21930731
    [PubMed - indexed for MEDLINE]
    2.

    Interferon lambdas: the next cytokine storm.

    Kelly C, Klenerman P, Barnes E.

    Gut. 2011 Sep;60(9):1284-93. Epub 2011 Feb 8. Review.

    PMID:
    21303914
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    T cell responses in hepatitis C: the good, the bad and the unconventional.

    Klenerman P, Thimme R.

    Gut. 2011 Aug 28. [Epub ahead of print]

    PMID:
    21873736
    [PubMed - as supplied by publisher]
    4.

    Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3.

    Thompson AJ, Patel K, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Rustgi VK, Flisiak R, Pianko S, Diago M, Arora S, Foster GR, Torbenson M, Benhamou Y, Nelson DR, Sulkowski MS, Zeuzem S, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-1 and ACHIEVE-2/3 Study Teams.

    Gut. 2012 Jan;61(1):128-34. Epub 2011 Aug 26.

    PMID:
    21873466
    [PubMed - indexed for MEDLINE]
    5.

    Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production.

    Brenndörfer ED, Brass A, Söderholm J, Frelin L, Aleman S, Bode JG, Sällberg M.

    Gut. 2012 Apr;61(4):589-96. Epub 2011 Aug 3.

    PMID:
    21813471
    [PubMed - indexed for MEDLINE]
    6.

    Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.

    Fitzmaurice K, Petrovic D, Ramamurthy N, Simmons R, Merani S, Gaudieri S, Sims S, Dempsey E, Freitas E, Lea S, McKiernan S, Norris S, Long A, Kelleher D, Klenerman P.

    Gut. 2011 Nov;60(11):1563-71. Epub 2011 May 6.

    PMID:
    21551190
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Transient elastography in chronic viral hepatitis: a critical appraisal.

    Cardoso AC, Carvalho-Filho RJ, Marcellin P.

    Gut. 2011 Jun;60(6):759-64. Epub 2011 Mar 29. Review. No abstract available.

    PMID:
    21450696
    [PubMed - indexed for MEDLINE]
    8.

    Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes.

    Melgar-Lesmes P, Pauta M, Reichenbach V, Casals G, Ros J, Bataller R, Morales-Ruiz M, Jiménez W.

    Gut. 2011 Oct;60(10):1404-11. Epub 2011 Mar 29.

    PMID:
    21450694
    [PubMed - indexed for MEDLINE]
    9.

    Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.

    Miquilena-Colina ME, Lima-Cabello E, Sánchez-Campos S, García-Mediavilla MV, Fernández-Bermejo M, Lozano-Rodríguez T, Vargas-Castrillón J, Buqué X, Ochoa B, Aspichueta P, González-Gallego J, García-Monzón C.

    Gut. 2011 Oct;60(10):1394-402. Epub 2011 Jan 26.

    PMID:
    21270117
    [PubMed - indexed for MEDLINE]
    10.

    Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.

    El-Serag HB, Kramer JR, Chen GJ, Duan Z, Richardson PA, Davila JA.

    Gut. 2011 Jul;60(7):992-7. Epub 2011 Jan 21.

    PMID:
    21257990
    [PubMed - indexed for MEDLINE]
    11.

    Insulin resistance and hepatitis C: an evolving story.

    Eslam M, Khattab MA, Harrison SA.

    Gut. 2011 Aug;60(8):1139-51. Epub 2011 Jan 19. Review.

    PMID:
    21252203
    [PubMed - indexed for MEDLINE]
    12.

    Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.

    Thomson EC, Fleming VM, Main J, Klenerman P, Weber J, Eliahoo J, Smith J, McClure MO, Karayiannis P.

    Gut. 2011 Jun;60(6):837-45. Epub 2010 Dec 7.

    PMID:
    21139063
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy.

    Hayes CN, Kobayashi M, Akuta N, Suzuki F, Kumada H, Abe H, Miki D, Imamura M, Ochi H, Kamatani N, Nakamura Y, Chayama K.

    Gut. 2011 Feb;60(2):261-7. Epub 2010 Nov 10.

    PMID:
    21068134
    [PubMed - indexed for MEDLINE]
    14.

    Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2.

    Lee MH, Yang HI, Jen CL, Lu SN, Yeh SH, Liu CJ, You SL, Sun CA, Wang LY, Chen WJ, Chen CJ; R.E.V.E.A.L.-HCV Study Group.

    Gut. 2011 May;60(5):688-94. Epub 2010 Nov 10.

    PMID:
    21068131
    [PubMed - indexed for MEDLINE]
    15.

    HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt.

    Paez Jimenez A, Sharaf Eldin N, Rimlinger F, El-Daly M, El-Hariri H, El-Hoseiny M, Mohsen A, Mostafa A, Delarocque-Astagneau E, Abdel-Hamid M, Fontanet A, Mohamed MK, Thiers V.

    Gut. 2010 Nov;59(11):1554-60.

    PMID:
    20947889
    [PubMed - indexed for MEDLINE]
    16.

    Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.

    Patel H, Heathcote EJ.

    Gut. 2011 Jun;60(6):879. Epub 2010 Oct 21. No abstract available.

    PMID:
    20966029
    [PubMed - indexed for MEDLINE]
    17.

    Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C.

    Svegliati-Baroni G, Faraci G, Fabris L, Saccomanno S, Cadamuro M, Pierantonelli I, Trozzi L, Bugianesi E, Guido M, Strazzabosco M, Benedetti A, Marchesini G.

    Gut. 2011 Jan;60(1):108-15. Epub 2010 Oct 21.

    PMID:
    20966027
    [PubMed - indexed for MEDLINE]
    18.

    Kinase inhibitors in the treatment of chronic hepatitis C virus.

    Bardou-Jacquet E, Lorho R, Guyader D.

    Gut. 2011 Jun;60(6):879-80. Epub 2010 Oct 21. No abstract available.

    PMID:
    20966026
    [PubMed - indexed for MEDLINE]
    19.

    Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection.

    Bridge SH, Sheridan DA, Felmlee DJ, Nielsen SU, Thomas HC, Taylor-Robinson SD, Neely RD, Toms GL, Bassendine MF.

    Gut. 2011 May;60(5):680-7. Epub 2010 Oct 12.

    PMID:
    20940286
    [PubMed - indexed for MEDLINE]
    20.

    Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins.

    Mancone C, Steindler C, Santangelo L, Simonte G, Vlassi C, Longo MA, D'Offizi G, Di Giacomo C, Pucillo LP, Amicone L, Tripodi M, Alonzi T.

    Gut. 2011 Mar;60(3):378-86. Epub 2010 Oct 12.

    PMID:
    20940285
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk